179 related articles for article (PubMed ID: 36810118)
21. Alpha-methyl CoA racemase (AMACR) reactivity across the spectrum of clear cell renal cell neoplasms.
Rotterova P; Alaghehbandan R; Skopal J; Rogala J; Slisarenko M; Strakova Peterikova A; Michalova K; Montiel DP; Farcas M; Ulamec M; Stransky P; Fiala O; Pitra T; Hora M; Michal M; Pivovarcikova K; Hes O
Ann Diagn Pathol; 2024 Mar; 71():152297. PubMed ID: 38579443
[TBL] [Abstract][Full Text] [Related]
22. Contemporary assessment of the correlation between Bosniak classification and histological characteristics of surgically removed atypical renal cysts (UroCCR-12 study).
Nouhaud FX; Bernhard JC; Bigot P; Khene ZE; Audenet F; Lang H; Bergerat S; Fraisse G; Grenier N; Cornelis F; Nedelcu C; Béjar S; Fromont-Hankard G; Allory Y; Lindner V; Verkarre V; Daniel L; Yacoub M; Correas JM; Méjean A; Rioux-Leclercq N; Bensalah K
World J Urol; 2018 Oct; 36(10):1643-1649. PubMed ID: 29730837
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma.
Wu S; Wang Y; Sun L; Zhang Z; Jiang Z; Qin Z; Han H; Liu Z; Li X; Tang A; Gui Y; Cai Z; Zhou F
BMC Cancer; 2011 Sep; 11():413. PubMed ID: 21943117
[TBL] [Abstract][Full Text] [Related]
24. [Clear cell papillary renal cell carcinoma: a distinct low-grade renal tumour].
Yang X; Miao N; Gan H; Wang L; Wang C
Zhonghua Bing Li Xue Za Zhi; 2015 Jun; 44(6):372-6. PubMed ID: 26704829
[TBL] [Abstract][Full Text] [Related]
25. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
[TBL] [Abstract][Full Text] [Related]
26. VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma.
von Teichman A; Compérat E; Behnke S; Storz M; Moch H; Schraml P
Mod Pathol; 2011 Apr; 24(4):571-8. PubMed ID: 21151099
[TBL] [Abstract][Full Text] [Related]
27. Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile.
Williamson SR; Eble JN; Cheng L; Grignon DJ
Mod Pathol; 2013 May; 26(5):697-708. PubMed ID: 23238627
[TBL] [Abstract][Full Text] [Related]
28. Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer.
Mertz KD; Demichelis F; Sboner A; Hirsch MS; Dal Cin P; Struckmann K; Storz M; Scherrer S; Schmid DM; Strebel RT; Probst-Hensch NM; Gerstein M; Moch H; Rubin MA
Int J Cancer; 2008 Aug; 123(3):569-76. PubMed ID: 18478571
[TBL] [Abstract][Full Text] [Related]
29. Cystic Features in Renal Epithelial Neoplasms and Their Increasing Clinical and Pathologic Significance.
Tretiakova M; Kwon JW; Paner GP
Adv Anat Pathol; 2024 May; 31(3):157-168. PubMed ID: 38525552
[TBL] [Abstract][Full Text] [Related]
30. Multilocular cystic renal cell carcinoma: pathological t staging makes no difference to favorable outcomes and should be reclassified. Bhatt JR, Jewett MA, Richard PO, Kawaguchi S, Timilshina N, Evans A, Alibhai S, Finelli A.J Urol. November 2016;196(5):1350-1355.
Kryvenko ON
Urol Oncol; 2017 Jun; 35(6):450-451. PubMed ID: 28416104
[TBL] [Abstract][Full Text] [Related]
31. MED15::TFE3 fusion renal cell carcinoma with extensive cystic change: A clinicopathologic and molecular genetic study of 2 cases, with an emphasis on differential diagnosis.
Yin X; Hu X; Xu J; Xiong D; Zhao M
Am J Clin Pathol; 2024 Feb; ():. PubMed ID: 38387043
[TBL] [Abstract][Full Text] [Related]
32. Xp11 translocation renal cell carcinoma and clear cell renal cell carcinoma with TFE3 strong positive immunostaining: morphology, immunohistochemistry, and FISH analysis.
Yang B; Duan H; Cao W; Guo Y; Liu Y; Sun L; Zhang J; Sun Y; Ma Y
Mod Pathol; 2019 Oct; 32(10):1521-1535. PubMed ID: 31175325
[TBL] [Abstract][Full Text] [Related]
33. Clear cell papillary renal cell carcinoma: Incidence, morphological features, immunohistochemical profile, and biologic behavior: A single institution study.
Alexiev BA; Drachenberg CB
Pathol Res Pract; 2014 Apr; 210(4):234-41. PubMed ID: 24485757
[TBL] [Abstract][Full Text] [Related]
34. Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes.
Baniak N; Flood TA; Buchanan M; Dal Cin P; Hirsch MS
Histopathology; 2020 Oct; 77(4):659-666. PubMed ID: 32639054
[TBL] [Abstract][Full Text] [Related]
35. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O
Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338
[TBL] [Abstract][Full Text] [Related]
36. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACKD-RCC)-like Cysts.
Sun Y; Argani P; Tickoo SK; Epstein JI
Am J Surg Pathol; 2018 Oct; 42(10):1396-1401. PubMed ID: 30001236
[TBL] [Abstract][Full Text] [Related]
37. Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings.
Hindman NM; Bosniak MA; Rosenkrantz AB; Lee-Felker S; Melamed J
AJR Am J Roentgenol; 2012 Jan; 198(1):W20-6. PubMed ID: 22194510
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation].
Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511
[TBL] [Abstract][Full Text] [Related]
39. Unlike in clear cell renal cell carcinoma, KRAS is not mutated in multilocular cystic clear cell renal cell neoplasm of low potential.
Raspollini MR; Castiglione F; Martignoni G; Cheng L; Montironi R; Lopez-Beltran A
Virchows Arch; 2015 Dec; 467(6):687-693. PubMed ID: 26438300
[TBL] [Abstract][Full Text] [Related]
40. Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.
Mikami S; Mizuno R; Kosaka T; Saya H; Oya M; Okada Y
Int J Cancer; 2015 Apr; 136(7):1504-14. PubMed ID: 25123505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
